In­fin­i­ty Phar­ma­ceu­ti­cals files for bank­rupt­cy af­ter lay­offs, scrapped merg­er with MEI Phar­ma

In­fin­i­ty Phar­ma­ceu­ti­cals filed for Chap­ter 11 bank­rupt­cy in a Delaware court last Fri­day, a lit­tle over two months af­ter it laid off about 78% of its work­force fol­low­ing a failed merg­er with MEI Phar­ma.

In SEC fil­ings, the com­pa­ny said it had hired a firm for po­ten­tial sales of any of its as­sets, in­clud­ing its can­cer drug eganelis­ib. In­fin­i­ty added in the fil­ings that for­mer CEO Ade­lene Perkins re­signed on Sept. 28 as chair of the board, though it was not “the re­sult of any dis­agree­ment” with the com­pa­ny. In­fin­i­ty al­so ex­pects the Chap­ter 11 fil­ing will can­cel or ex­tin­guish all out­stand­ing cap­i­tal stock with­out any pay­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER